Bharat Biotech Chairman Meets Odisha CM
Major vaccine facility in Bhubaneswar set to boost healthcare and create thousands of jobs
Dr Krishna Ella, Chairman of Bharat Biotech, met Odisha Chief Minister Mohan Charan Majhi at Lok Seva Bhavan on Wednesday to discuss the company’s future expansion and Odisha’s growing role in vaccine manufacturing.
During the meeting, Dr Ella shared updates about Sapigen Biologix Private Limited—a subsidiary of Biovet Pvt Ltd, which he promotes. The company has already set up a massive vaccine production plant at the Biotech Park in Andharua, located on the outskirts of Bhubaneswar. Built with an investment of Rs 1,500 crore, the advanced facility is among the largest vaccine manufacturing units in the country.
The Andharua plant spans across 10 acres and is designed to produce vaccines for more than 10 life-threatening diseases including polio, cholera, and malaria. With an annual production capacity of eight billion doses, the facility is expected to play a key role in both national and global public health.
In the meeting, Dr Ella and his team also spoke about building a strategic partnership with the Odisha government to strengthen healthcare infrastructure and encourage local employment.
Sapigen Biologix is projected to create around 2,000 direct jobs and over 1,500 indirect employment opportunities. This development is expected to boost the local economy and help develop skilled manpower in the biotechnology sector.
Chief Minister Majhi expressed strong support for the initiative and assured all possible help from the state government. He said the state is committed to becoming a global hub for vaccine production, which will not only boost public health but also establish Odisha as a key player in India’s biotech industry.
This visit marks an important step in Odisha’s journey to becoming a leading centre for biotech and pharmaceutical investments. With such large-scale projects and partnerships, the state is positioning itself as a major contributor to global healthcare solutions.
Officials from Bharat Biotech and Sapigen Biologix, along with senior government representatives, were present during the discussions.
